Upadacitinib in end stage renal disease: A case of acute severe ulcerative colitis

Upadacitinib in end stage renal disease: A case of acute severe ulcerative colitis

Abstract Recent data, indicating that inflammatory bowel disease (IBD) may be a risk factor for future chronic kidney disease, highlight the need to study the safety and clinical effectiveness of advanced IBD therapies in patients with end stage renal disease (ESRD), defined as an eGFR <15 mL/min...

Full description

Bibliographic Details
Main Authors: Patrick Hilley, Danny Con, Matthew C. Choy, Ashish Srinivasan, Peter De Cruz
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:JGH Open
Subjects:
acute severe ulcerative colitis
end stage renal disease
janus kinase inhibitor
upadacitinib
Online Access:https://doi.org/10.1002/jgh3.13015

Similar Items

Similar Items